Applied Genetic Technologies Corp AGTC

NAS: AGTC | ISIN: US03820J1007 30/11/2022

0,394 USD (+1,23%)

(+1,23%) 30/11/2022

Toon enkel gratis nieuws

14 mei 2021 · Concept Companies Breaks Ground on Expansion for AGTC in Alachua's Foundation Park · Persbericht

18 maart 2021 · AGTC to Present at the Gene Therapy Patient Engagement Summit, Held Virtually, March 24, 2021 · Persbericht

2 maart 2021 · AGTC to Present at Upcoming Investor Conferences · Persbericht

16 februari 2021 · AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021 · Persbericht

16 februari 2021 · AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 2021 · Persbericht

11 februari 2021 · AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2020 · Persbericht

4 februari 2021 · AGTC Executives Awarded First Place in the BioProcess International Reader’s Choice Awards, Cell & Gene Therapies Category · Persbericht

4 februari 2021 · AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 11, 2021 · Persbericht

28 januari 2021 · AGTC Announces Pricing of Public Offering of Common Stock and Warrants · Persbericht

27 januari 2021 · AGTC Announces Proposed Public Offering of Common Stock and Warrants · Persbericht

27 januari 2021 · AGTC Announces First Reported Improvements in Visual Sensitivity for Achromatopsia (ACHM) patients from its Ongoing Clinical Trials · Persbericht

6 januari 2021 · AGTC to Participate in the H.C. Wainwright BioConnect 2021 Conference · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe